Advagene Biopharma Co. Ltd.
6709StockTW
25.00 ▲ +1.63%
12 juin 2026
6
Advagene Biopharma Co. Ltd.
25.00 ▲ +1.63%
12 juin 2026
6709StockTW

01 / À propos

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine; respiratory allergy treatment vaccine, including rhinitis and asthma; COVID-19 immunotherapy; and other vaccines. The company was founded in 2006 and is based in Taipei, Taiwan.

Arberion
Loading market data